BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1136@pharmaconomics
DTSTAMP:20260707T051214Z
DTSTART;VALUE=DATE:20260228
DTEND;VALUE=DATE:20260301
SUMMARY:ASND PDUFA — TransCon CNP
DESCRIPTION:The FDA's approval decision on TransCon CNP for pediatric achondroplasia is due Feb 28\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1612042/000119312526009636/d13397d6k.htm\n\nTrack it: https://www.pharmaconomics.com/e/1136
URL:https://www.pharmaconomics.com/e/1136
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ASND catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR